Search Results - "Faje, Alexander"

Refine Results
  1. 1

    Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights by Faje, Alexander

    Published in Pituitary (01-02-2016)
    “…Introduction Advances in immunotherapy have transformed the management of metastatic melanoma and generated encouraging results in the treatment of other…”
    Get full text
    Journal Article Book Review
  2. 2

    High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma by Faje, Alexander T., Lawrence, Donald, Flaherty, Keith, Freedman, Christine, Fadden, Riley, Rubin, Krista, Cohen, Justine, Sullivan, Ryan J.

    Published in Cancer (15-09-2018)
    “…BACKGROUND It remains unclear whether high doses of glucocorticoids have a negative impact on the efficacy of checkpoint inhibitors. To control for the…”
    Get full text
    Journal Article
  3. 3

    Ipilimumab-Induced Hypophysitis: A Detailed Longitudinal Analysis in a Large Cohort of Patients With Metastatic Melanoma by Faje, Alexander T, Sullivan, Ryan, Lawrence, Donald, Tritos, Nicholas A, Fadden, Riley, Klibanski, Anne, Nachtigall, Lisa

    “…Context: Ipilimumab (Ipi) is approved by the Food and Drug Administration for the treatment of unresectable or metastatic melanoma. Little is known about…”
    Get full text
    Journal Article
  4. 4

    Pituitary Complications of Checkpoint Inhibitor Use by Chamorro-Pareja, Natalia, Faje, Alexander T, Miller, Karen K

    Published in Endocrinology (Philadelphia) (26-07-2024)
    “…Abstract Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including…”
    Get full text
    Journal Article
  5. 5

    Chronic lymphocytic leukemia, a rare cause of pituitary stalk thickening by Faje, Alexander

    Published in Clinical case reports (01-07-2020)
    “…This case highlights a rare presentation of chronic lymphocytic leukemia (CLL). CNS involvement by CLL is rare, and only 5 cases with pituitary or hypothalamic…”
    Get full text
    Journal Article
  6. 6

    Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis by Faje, Alexander, Reynolds, Kerry, Zubiri, Leyre, Lawrence, Donald, Cohen, Justine V, Sullivan, Ryan J, Nachtigall, Lisa, Tritos, Nicholas

    Published in European journal of endocrinology (01-09-2019)
    “…Objective Little has been published describing hypophysitis after nivolumab or pembrolizumab treatment. We aimed to (i) assess the risk of hypophysitis…”
    Get full text
    Journal Article
  7. 7

    Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors by Seethapathy, Harish, Rusibamayila, Nifasha, Chute, Donald F, Lee, Meghan, Strohbehn, Ian, Zubiri, Leyre, Faje, Alexander T, Reynolds, Kerry L, Jhaveri, Kenar D, Sise, Meghan E

    Published in Nephrology, dialysis, transplantation (02-12-2021)
    “…Abstract Background Hyponatremia due to endocrinopathies such as adrenal insufficiency and hypothyroidism has been reported in patients receiving immune…”
    Get full text
    Journal Article
  8. 8

    Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa by Faje, Alexander T., Fazeli, Pouneh K., Miller, Karen K., Katzman, Debra K., Ebrahimi, Seda, Lee, Hang, Mendes, Nara, Snelgrove, Deirdre, Meenaghan, Erinne, Misra, Madhusmita, Klibanski, Anne

    “…ABSTRACT Objective To (i) compare fracture prevalence in adolescent females with anorexia nervosa (AN) versus normal‐weight controls and (ii) examine whether…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial by Fazeli, Pouneh K, Lawson, Elizabeth A, Faje, Alexander T, Eddy, Kamryn T, Lee, Hang, Fiedorek, Fred T, Breggia, Anne, Gaal, Ildiko M, DeSanti, Rebecca, Klibanski, Anne

    Published in The journal of clinical psychiatry (01-01-2018)
    “…To assess the effects of relamorelin-an agonist of the appetite-stimulating hormone ghrelin, which has effects on gastric emptying-on (1) weight gain and (2)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease by Amlashi, Fatemeh G, Swearingen, Brooke, Faje, Alexander T, Nachtigall, Lisa B, Miller, Karen K, Klibanski, Anne, Biller, Beverly M.K, Tritos, Nicholas A

    “…Context: Late-night salivary cortisol (LNSC) is well-validated in the diagnosis of Cushing's disease (CD). The accuracy of LNSC during follow-up of patients…”
    Get full text
    Journal Article
  16. 16

    Changes in marrow adipose tissue with short-term changes in weight in premenopausal women with anorexia nervosa by Fazeli, Pouneh K, Faje, Alexander T, Bredella, Miriam A, Polineni, Sai, Russell, Stephen, Resulaj, Megi, Rosen, Clifford J, Klibanski, Anne

    Published in European journal of endocrinology (01-03-2019)
    “…Objective In anorexia nervosa, a psychiatric disease characterized by self-induced starvation and a model of chronic undernutrition, levels of subcutaneous…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa by Fazeli, Pouneh K, Faje, Alexander T, Cross, Ela J, Lee, Hang, Rosen, Clifford J, Bouxsein, Mary L, Klibanski, Anne

    Published in Bone (New York, N.Y.) (01-08-2015)
    “…Abstract Background Anorexia nervosa (AN) is a psychiatric disorder characterized by self-induced starvation and low body weight. Women with AN have impaired…”
    Get full text
    Journal Article
  19. 19
  20. 20